2026年9月15日•3分で読めます
FDA Approves ANDA087129 for Cyproheptadine Hydrochloride Tablet
FDA has approved ANDA087129 for a 4 mg oral tablet of Cyproheptadine Hydrochloride, sponsored by Strides Pharma Intl, with a history of labeling and manufacturing supplements.